Alpenglow Biosciences and CorePlus partner together to bring 3D Spatial Biology to clinical research and development

Written By Nick Reder

Alpenglow today announced a partnership with CorePlus, a high complexity CLIA-certified clinical and anatomic pathology laboratory, to digitize and analyze tissues in 3D to deliver novel spatial biology insights and accelerate drug development. As part of the partnership, CorePlus will invest an undisclosed sum into Alpenglow and receive access to Alpenglow's 3Deep Imager, a patented hybrid open-top light-sheet imaging platform.

Nick Reder
Previous

Alpenglow’s 3D Spatial Biology platform supports Cell Reports journal publication with 3D imaging of intact prostates
Next

Alpenglow Biosciences Unveils Fully Integrated “3Deep” Offering at BIO2022 Bringing AI-Powered, 3D Insights to Spatial Biology